載入...

DIPG-25. GENETIC ALTERATIONS TARGETING THE MAPK PATHWAY CONFERS PRECLINICAL SENSITIVITY TO TRAMETINIB IN A CO-CLINICAL TRIAL IN DIPG

The survival of children with DIPG remains dismal, and new treatments are desperately needed. The development of patient-specific in vitro and in vivo models represents one such opportunity, however the time taken to establish such models and the rapid disease progression has been thought to limit t...

全面介紹

Na minha lista:
書目詳細資料
發表在:Neuro Oncol
Main Authors: Izquierdo, Elisa, Carvalho, Diana, Boult, Jessica, Mackay, Alan, Temelso, Sara, Molinari, Valeria, Stubbs, Mark, Burke, Rosemary, Depani, Sarita, O’Hare, Patricia, Robinson, Simon, Hubank, Michael, Hargrave, Darren, Jones, Chris
格式: Artigo
語言:Inglês
出版: Oxford University Press 2019
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477199/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz036.046
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!